Jaguar's novel plant-based prescription drug crofelemer has been granted Orphan Drug Designation by the FDA and the European Medicines Agency for both MVID and short bowel syndrome (SBS) with intestinal failure
Proof-of-concept studies of crofelemer for MVID and SBS planned for 2024
Read More
Sumitomo Corporation Power & Mobility, a 100% subsidiary of Sumitomo Corporation and Electrovaya have expanded their sales partnership with a formal supply agreement with the intention to supply battery modules to a leading Japanese construction equipment OEM
Read More
A deadline is coming up on May 20th in the lawsuit that was filed for certain investors in share of the Chemours Company (NYSE: CC) and NYSE: CC investors should contact the Shareholders Foundation.
Read MoreA lawsuit is pending for certain investors in Sunnova Energy International Inc. (NYSE: NOVA) shares and NYSE: NOVA investors should contact the Shareholders Foundation, Inc
Read More